Informationen:
Fehler:
ID
12600
Beschreibung
A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF); ODM derived from: https://clinicaltrials.gov/show/NCT01067859
Link
https://clinicaltrials.gov/show/NCT01067859
Stichworte
Versionen (1)
- 04.12.15 04.12.15 -
Hochgeladen am
4. Dezember 2015
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Acute Heart Failure NCT01067859
Eligibility Acute Heart Failure NCT01067859
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Acute Heart Failure NCT01067859
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Patient age and sex
Item
male and female subjects, age >/= 18 years of age;
boolean
C0150831 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Postmenopausal women
Item
Postmenopausal women aged 18 years or older.
boolean
C0232970 (UMLS CUI [1])
adequate contraceptive methods
Item
women with bilateral tubal ligation, women with bilateral ovariectomy, and women with a hysterectomy
boolean
C0700589 (UMLS CUI [1])
subjects must have the clinical diagnosis of congestive heart failure (chf) made at least three months prior to enrollment
Item
subjects must have the clinical diagnosis of congestive heart failure (chf) made at least three months prior to enrollment
boolean
C0018802 (UMLS CUI [1])
subjects must experience worsening of both of the symptoms below leading to hospitalization at the time of entry into the study
Item
subjects must experience worsening of both of the symptoms below leading to hospitalization at the time of entry into the study:
boolean
C1821820 (UMLS CUI [1])
C0019993 (UMLS CUI [2])
C0019993 (UMLS CUI [2])
dyspnea
Item
dyspnea
boolean
C0013404 (UMLS CUI [1])
clinical evidence of volume overload
Item
clinical evidence of volume overload
boolean
C2236137 (UMLS CUI [1])
Pregnancy or breastfeeding
Item
Pregnancy or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
acute new heart failure
Item
acute de-novo heart failure
boolean
C0742752 (UMLS CUI [1])
acute myocardial infarction
Item
acute myocardial infarction and/or myocardial infarction within 30 days
boolean
C0155626 (UMLS CUI [1])
valvular heart disease
Item
valvular heart disease requiring surgical intervention during the course of the study
boolean
C0018824 (UMLS CUI [1])
heart failure due to or associated with uncorrected primary valvular disease, malfunctioning artificial heart valve, or uncorrected congenital heart disease
Item
heart failure due to or associated with uncorrected primary valvular disease, malfunctioning artificial heart valve, or uncorrected congenital heart disease
boolean
C0018801 (UMLS CUI [1])
C0018824 (UMLS CUI [2])
C0152021 (UMLS CUI [3])
C0018824 (UMLS CUI [2])
C0152021 (UMLS CUI [3])
primary hypertrophic cardiomyopathy
Item
primary hypertrophic cardiomyopathy
boolean
C0264847 (UMLS CUI [1])
acute inflammatory heart disease, eg, acute myocarditis
Item
acute inflammatory heart disease, eg, acute myocarditis
boolean
C0155686 (UMLS CUI [1])
C0031046 (UMLS CUI [2])
C0014118 (UMLS CUI [3])
C0031046 (UMLS CUI [2])
C0014118 (UMLS CUI [3])
unstable angina
Item
unstable angina requiring angiography
boolean
C0002965 (UMLS CUI [1])